Drug Profile
SNX 024
Latest Information Update: 20 Jul 1998
Price :
$50
*
At a glance
- Originator Elan Pharmaceuticals
- Class Appetite stimulants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alcoholism; Obesity
Most Recent Events
- 20 Jul 1998 No-Development-Reported for Alcoholism in USA (Unknown route)
- 20 Jul 1998 No-Development-Reported for Obesity in USA (Unknown route)
- 13 Nov 1995 New profile